Good morning, investors, analysts, and friends from the capital markets. Thank you for attending Ping An Healthcare and Technology Company Limited 2025 interim results announcement. I'm Liu Chen, board secretary and moderator for today's presentation. First of all, please allow me to introduce the management team who are here today with us. They are Chairman of the Board and Chief Executive Officer, Mr. Li Dou. Executive Director, Executive Vice President, and Chief Financial Officer, Ms. Fang Ruoqi. Senior Vice President and Chief Technology Officer, Mr. He Lichuan. Today's presentation will be consisted of two parts. In part one, Mr. Li Dou and Ms. Fang Ruoqi will present the company's business results, business progress during the reporting period, and provide an outlook on the company's strategy and development. In the second part of the meeting, Mr. Li, Ms. Fang, and Mr. He will answer your questions.
Investors and analysts at venue and online would be able to raise your questions. For the on-site investors and analysts, if you'd like to ask a question, please put up your hands. We're going to put the circulating microphone to you. Well, for investors and analysts who are attending the meeting online, please press star and one to raise your question. Right before we start the meeting, I will read the cautionary statements regarding forward-looking statements for today's presentation. To the extent any statement made in today's presentation is also a common practice of all the meetings we hold, I'm not going to elaborate here.
The meeting will be conducted in Mandarin. For any of the on-site audience, please make sure you mute your smartphones. Ladies and gentlemen, now I'd like to announce the 2025 interim result announcement of Ping An Healthcare and Technology Company starts now. First of all, we'd like to welcome Ms. Fang to walk us through the performance of the company as a whole, please.
Good morning, friends from the capital markets. In 2025, we remain true to our original mission. As a flagship of Ping An Group's health and senior care ecosystem, we have been resolutely implementing our strategy, leveraging our unique strategy advantage and resource involvement. Acting for the three major payers, the company focuses on the healthcare needs of integrated finance and insurance customers, as well as enterprises and their employees in each one of Asia. We see the growth trends in the health industry and source and integrated high-quality provider resources through a combination of the asset light and asset heavy model. We enhance the service efficiency of the family doctor and the senior care concierge, consolidate user traffic portals, and provide proactive operations and precision guidance.
Over the past year, we also strengthened the transformation and driving of the artificial intelligence, vigorously promote AI application, and also innovate for AI doctor product and service ecosystem, making medical visits and health consumption more worry-free, time-saving, and money-saving for users. Following the above strategies, over the past six months, we have further leveraged the resources advantage of Ping An Group's health and senior care ecosystem, deepen synergies and enablement of the core financial business and insurance business. During the reporting period, the F&B and strategic business grew rapidly, paying user reached 24 million, growing by 35%. As a consolidated subsidiary of Ping An Group, we provide health and senior care services to group integrated finance customers, provide diversified service, and now run deeper integration, where F&P users significantly increased to 20 million.
Meanwhile, we accelerated the development of the B-end and corporate health management business, establishing health protection plans for enterprises and their employees. The number of paying corporate clients and employees grew rapidly, reaching 2,500 in each one of Asia. In terms of the service, the two major hubs of the Family Doctor and the Senior Care Concierge continue to enhance the service quality with ever-expanding membership. Users entitled to Family Doctor service benefits exceed 35 million with 150% growth. Users entitled to Senior Care Concierge benefits grew by 83%. We also strengthened the construction of the online, in-store, in-home, and in-company service network with 50,000 in-house doctors and over 3,200 contracted renowned external doctors. Services cover 85 cities, meeting the user's needs from both online and offline channels. In addition, the company continued to strengthen AI capacity and scenario-building applications.
In June of this year, we launched the 7 plus 10 plus 1 AI product matrix with remarkable results in AI technology enablement. Throughout the reporting period, daily consultation requests doctors can handle with AI assistance reaching 4 million, AI-assisted inquiry and consultation accuracy rate reaching 98%, MDT critical illness treatment accuracy rate reached 80%, significantly improved medical visit efficiency and prioritization and application of the high-quality medical resources. Benefiting from above business progress, during the reporting period, our revenues grew to RMB 2.5 billion, up 20% year-over-year due to the insurance plus healthcare synergy and accelerated corporate health management business. F&D revenue and B-end corporate health management revenue reached RMB 1.96 billion, up 30%. During the reporting period, the company's GP margin was 33.6%, showing steady improvement YoY and QoQ, reflecting AI application to further improve the doctor service efficiency per capita.
In each of this year, we're maintaining the high growth, the company profitability continued to improve. After we have a transition to profitability in 2024, our net profit attributable to the shareholder of the parent company reached 130 million RMB in H1 of 2025. Net profit margin attributable to the shareholder of the parent company reached 5.4%. Adjusted net profit reached 160 million RMB, grow by 84%, with adjusted net profit margin reaching 6.6%. During the reporting period, the revenue and business segment achieved sound growth with optimization on revenue structure. From a product perspective, medical service revenue increased by 20.2%, reaching 1.28 billion RMB. Family Doctor specialist service, renowned doctors, and more medical visit assistants is becoming more deepened by having insurance plus healthcare synergy.
While at the same time, we are also capturing the development in consumer health, continue to improve the service for the checkups, management service, life scenarios. Senior care service continued with a high growth momentum from 2024, achieving a revenue growth of more than 260%. Let's take a look at the channels F&D and B&D. Corporate health management business continue to grow. F&D revenue grew by 28.5%, reaching RMB 1.43 billion. Because of the high-quality whole process medical and health service, based on the user needs and user record, we continue to improve the user stickiness to empower the development of our core financial business. The company also works with the group to accelerate the expansion of the B&D corporate health management business, enriching medical and health service product portfolio, deepen in-company service operation, improving employee service utilization. The B&D revenue increased by 35.2%, reaching RMB 530 million.
During the reporting period, GP margin and the gross profit all improved. Gross profit increased by 24.6%, GP margin reaching 33.6%, up by 1.4% compared with last year. There are three reasons for the gross profit growth. First of all, with AI technology enablement, doctor service efficiency continued to improve. Taking Family Doctor as an example, average service cost per customer decreased by 52% worldwide, enabling doctors to provide longer, efficient, and targeted service to each user. Secondly, the company's business structure continued to be optimized. With continuous improvement of the medical and healthcare service capacity and increasing the rich product portfolio, the share of the service revenue with a higher gross margin increased by 4%. In addition, we continue to strengthen provider integration and enrich the medical and health service supply chain platform resources, continuing to steadily increase the company's platform business revenue.
In H1 of this year, with the deepening of the technology enablement for efficiency improvement and resources allocation, the total expense ratio decreased to 30.1%, a decline of 6.3%, achieving continuous improvement for four consecutive reporting periods. Significantly speaking, due to enhanced channel strength and stronger corporate client stickiness, and the renewal rate reached 80%, and the sales and marketing ratio down by 2.3%. On administrative expenses, the company promotes digital business operation and management, building a digital supply system, further using artificial intelligence for operations, resulting in a 2.7% decrease for administrative expenses ratio. We also attach great importance to medical AI capacity building, creating closed-loop throughput overall for the user's whole process, and we will be able to have a good decline, and the R&D expenses ratio was 6.5%, maintaining a high level in the industry due to the accelerated business growth and optimized supply chain management.
The operating cash flow after turning positive in 2024, we achieved a net flow of around RMB 64 million in H1 of 2025, demonstrating strong cash generation capacity, providing strong support for the subsequent business development and strategic investments. Meanwhile, the company's profitability also improved significantly. During the reporting period, net profit attributable to the shareholder of the parent company reached RMB 134 million, adjusted net profit reached RMB 165 million, achieving substantial worldwide growth, adjusted net profit margin reached 60.6%. As a technology company in the healthcare industry, Ping An always regard ESG philosophy as the indigenous growth driver of our sustainable growth. During the reporting period, we maintained MSCI ESG rating of double A and received significant awards as 2025 Forbes China Industrial Development ESG benchmark. In H1 of this year, we persisted on integrating ESG sustainable development philosophy into business development.
Through corporate health protection plans, we provide health management solutions to health check-ups, renowned doctor consultations, and medical visit assistants. We promote healthy journey, national health literacy improvement initiative, launching nationwide covering hundreds of districts and the sessions by entering Ping An enterprises and industrial parks to improve the happiness of the workplace. We have covered more than 3.6 million corporate employees throughout our initiatives and covering more than 6,000, 65,000 people. We also focus on technology enablement, driving green medical innovation. We also have a comprehensive 7 Plus N Plus 1 AI product system, full life cycle, covering all scenarios and complete ecosystems. We also have launched a MDT consultation, which has been implemented for breast cancer. Also, the company attaches great importance to data compliance and information security.
In H1 2025, we obtained the highest level certification for PIA issued by CAICT, China Academy of Information and Communications Technology, becoming one of the first companies nationwide to achieve this standard. We also build a green supply chain, improving our supply chain resilience and enhanced the standards and quality and the management. We established a supply chain risk management mechanism using the Eagle Eye System to cover 23 categories of core services. We also have real-time monitoring of key risk points to make sure we have win-win with our suppliers and development of the supply chain ecosystem. That's all for my overall business results introduction. Thank you all very much.
Well, thank you, Ms. Fang. Now, let me now give the floor to Mr. Li Dou, Chairman of the Board and CEO, to share the outlook of the company with everyone. Thank you.
Welcome all investors to join us online and offline for the interim results announcement. Just now, Ms. Fang has walked us through the company's financial highlights and performance. Now, from the operational perspective, I will share with everybody how we will continue to drive our business growth. In the first half of this year, we continue to promote synergy with Ping An Group, insurance companies, and banks. We have had very comprehensive and deep business collaboration with these partners. On F&D, we have cultivated two models: insurance plus health and senior care membership and medical and health benefit services. We enhanced our online, in-store, in-home, in-company proactive capabilities, strengthened our customer operation, injecting strong momentum to our growth.
In our membership model, we embedded health and senior care benefits into our customer policies, providing one-stop medical senior care services for critical illness insurance, million-yuan medical insurance savings insurance, and other types of insurance products. We have also differentiated our services targeting at different types of customers to increase their retention. Also, we have enriched and diversified the embedded product benefits, especially on stay-at-home tests, cancer diagnosis. We have also deepened the deployment of innovative service projects like life sciences tumor screening. By expanding service scenarios, we also have injected strong momentum into our products, especially promoted policy sales, renewals, and additional coverages. With these two models, we have made sure that our F&D business achieved great growth. The revenue reached RMB 1.43 billion, increased 28.5% year-on-year. Medical service revenue achieving growth of over 50%.
Number of paying users achieved 35% year-on-year growth to 20 million, demonstrating our strong momentum. Today, we also proactively worked with the companies from the basic healthcare systems to the medical supplements to health management. The company seized strategic development opportunities, collaborating with Ping An Group member companies to expand our corporate clients. During the reporting period, we have paying corporate clients exceeding 3,500 and B&P paying users exceeding 3.6 million, achieving growth of almost 40% year-on-year. In the same time, we optimize our service capabilities, providing more comprehensive one-stop service systems. For employees, we provide full scenario services like checkups, renowned doctor consultations online, medical visits assistance, convenient medicine purchasing, and chronic disease management. We have improved their health level and workplace happiness. For enterprise, we provide services like on-site medical help, in-company activities, and corporate health dashboards, helping enterprises build all-around healthy workplaces.
Also, during the reporting period, our B&P business also increased, especially improving the renewal rate of 80% for clients, and also we have a revenue reaching RMB 530 million. Corporate health management increase of 35.2% year-on-year. We also leverage medical AI to grow our members. Speaking of family doctors, the company has upgraded the family doctor services and operational system from basic medical care to critical illness case management. We better align our service with customer needs by expanding the application scenarios. On F&D, on safety and care, we have differentiated our services. On the senior care, we have upgraded our services, especially on medical health, safety, and care. We have upgraded our doctors to general practitioners with associate senior professional titles or above, with certification from PKU International Hospital and World Organization of Family Doctors.
In home safety, we provide with emergency rescue services, especially monitoring elderly home risks through smart devices. We also now collaborate with more than 100 elderly care institutions to provide nursing bed admission assistance. At the end of the reporting period, our home-based senior care services covered more than 85 cities, adding 10 cities compared to the end of last year, with users entitled to benefits growing rapidly by 83% year-on-year. During the reporting period, the company has persisted in being customer-centric, enriching our four availability network. We focus on healthcare in June this year. We have launched a number of initiatives like proactive family doctor care, zero distance renowned doctor access, and full process medical visits management through 7-24-hour family doctor consultation, renowned doctor audio-video service availability within three hours, worry-free full process medical visit assistance. We effectively improve the customer convenience in looking for medical care support.
Also, we diversify our service network. During the reporting period, we have had more than 50,000 in-house doctors and contracted external doctors, over 3,200 contracted renowned doctors, and nearly 106,000 health service providers, including nearly 3,300 health checkup institutions, meeting the needs of all customers. By more than 10 years of development, we have built the world's leading AI capability, relying on data models, scenario closed loop. We have constantly iterated and achieved breakthroughs on data. We own unique full-chain closed loop advantage in insurance and medical data, including our six globally leading databases, over 1.44 billion independently accumulated online consultation data points and more. Ping An Group's solid 953 technology system is also supporting the company in differentiating our competitiveness.
In terms of models, we have developed a Ping An Master LLM integrating with DeepSeek Q13 and built 5 major medical-specific models through continuous annotation and correction by our 500 in-house doctors. We have reduced AI hallucination and gained advantage in professional medical services. In scenarios, we have launched our AI product matrix in June this year, covering 7 major products like the digital avatar family doctors and senior care concierges. We also launched a complex disease multidisciplinary consultation assistant platform, which can be used for breast cancer and provide users with full process treatment and rehabilitation services, also saving the cost for patients seeking advanced medical care support. In terms of AI application, the company also achieved great breakthrough. We will continue to have vertical growth of AI so that we can have 98% of the AI-assisted inquiry and consultation accuracy rate.
We have MDT treatment plan accuracy rate reaching nearly 80% and daily consultation, which can handle AI-assisted consultation services covering four million people. On AI assistance, we also achieved comprehensive improvements in diagnosis and operational efficiency. For family doctors, we have managed to improve the average service cost per customer to have it decreased by 52% year-on-year. In the future, we will continue to develop the MDT and AI large models. By using and leveraging China's policies, we will make sure that we align our businesses for better growth. As the industry-leading platform, we will further align with Ping An Group. On one side, we will continue to build our in-store, in-home, in-company and online network, consolidating service providers, providing time-saving, money-saving services to all users.
On the other side, relying on Ping An's technology, financial resources, with the user traffic portal, utilizing our AI capability, we provide all scenarios comprehensive services. Now, the company has our very clear strategy, definite objectives. With our continuous growth, we will become China's number one portal for medical and health service. After the last two years of efforts, our F&D business model has been fully validated through the online in-store, in-home, in-company service network, and family doctor membership. We have built great user mindset and service reputation. We will continue to export this experience to our B-end and refine the full scenario, multi-tier end-to-end operational service system, and scale up the business. On provider integration, the company will focus on users' core health, medical, senior care needs, combining asset-light and asset-heavy approaches. We will continue to upgrade the online in-store, in-home, in-company self-service network.
Beyond self-development, we will also expand cooperation categories to meet users' full needs. Those who wanted to go afar must have very concrete plans, and those who work diligently will finally succeed. The company will continue to drive ahead with determination and contributing our share responsibility to support Health China realization.
Thank you to Mr. Li for such a grand summary. Now, let's move on to the second part of today's announcement. If you have any questions, dear investors and analysts, please raise your hand if you are here on site. If you're dialing online, please press star and one to raise your question. Okay, question from row number two.
Thank you for taking my question. My name is Zhou Ye from Citibank. In the first half of this year, F&D and B&O had revenue growth of more than 30%. What are the driving forces? What's your secret sauce? I know Mr. Li mentioned that Ping An Good Doctor's sales are now expanding clients with Ping An Group's sales. Can you share more stories on that end? Thank you.
I think that question really resonates to our business growth and our synergy with Ping An Group. I will ask Mr. Li Dou to take the question. Thank you. I think after the first half of the business growth, I think synergy and healthy growth with Ping An is the key. Speaking of synergy, on F&D, we're working very closely with Ping An, especially on life insurance. We have diversified our policy benefits. We have innovated our sales scenarios to support the policy customer acquisition and sales. In the same time, this year, we have expanded our collaboration with other channels from Ping An, like enterprise insurance and property insurance.
By service expansion, we made it very clear for enterprises that there are more services that Ping An and Ping An Good Doctor can provide. So there, you can also see robust growth. Highlighting our advantage on AI capability, you see the company has reached great breakthrough. This year, we have launched 7 Plus N Plus 1 AI matrix. Simply said, we have multiple AI products to serve our deepening customer needs.
It can also help us to continue to improve the operational efficiency, which can help us to further acquire the customer and expand the customer base, well, at the same time, we also continue to improve the Family Doctor and Senior Care Concierge, the two major business capacity building, and you can see many of our doctors being further upgraded.
They have the dual certifications, and we will be able to continue to serve the customer both online and offline. According to the financial performance, we actually realized a healthy growth. F&D is a cornerstone of our business with a steady growth, where the company's health management business also reaching our growth expectation. By having both business, the channel cooperation has been more streamlined with ever-improving synergetic effect. GP margin and gross profit all be improved with continued inflow of the cash. Indeed, the two enablements can actually help us to leverage Family Doctor as a key and build more service product to the C-end, and then support our insurance agent to dive deep into different business scenario and placing a low-frequency insurance business to become a high-frequency health and medical consultation service and business. Thank you. Thanks for Mr. Dou. Let me just briefly summarize.
The business highlights is to strengthen collaboration, highlighting our strengths for healthy growth. Let's also give the opportunity to the investors on-site visits, please. Thank you. Thanks for the management team. My name is Alex from Morgan Stanley. I have a question regarding the synergy with the group after being a part of the group onboard. So for Ping An Good Doctor, your strategic positioning, is it be changed? I mean, from the micro perspective, well, let's be more specific to the business. And after having the group as a shareholder, is there any synergy between the company and the group? Are there any new synergies we can expect in the near future? Thank you very much. Thanks for Alex. Thanks for your question. This is a question regarding the business synergy between the company and the group. We're going to have Mr. Li to respond to this question.
Thank you very much. To put it simple, after the consolidation, we will be a part of the Ping An Group ecosystem. In other words, we have diversified the source and the channel for the customer acquisition. You can see our F&D plus B business, the growth rate was more than 30%. More robust growth are coming from a B&D business. We leverage our service to continue to expand the enterprise's client. That is regarding the customer acquisition synergy. On the other side, because for Ping An Tech, we do have a very strong artificial intelligence, and we also have our own large language model, which has already been available for Ping An Good Doctors, large language models, the doctor workbench. We have more scenarios to deploy the AI to further improve the service capacity.
For our F&D customer, the service has been further deepened, starting from the general medical service to the consultation service to the critical care patient life cycle management, along with AI in the MDT consultation assistance. All those would be available because we have the in-depth customer health data, including the service scenario that can really unleash the great value from our basic service. On the other side, we do the service because we do have the online plus offline full availability networks integration. We are also working with the Peking University Medical Group, leveraging our resources to have the online offline full process and full chain management and service. Talking about the future, I think our business model is pretty well established.
We'd be happy to be a part of the integrated finance for medical and healthcare and outreach health strategy, continue to integrate the traffic and the customer source, leveraging our resources internally and externally, continue to expand our service scenario and product power using artificial intelligence to truly provide the time-saving, worry-free, and also the cost-saving service to the customers. Thank you. Thanks for Mr. Lee. We also have some investors from the online channel. The third question, let's welcome Mr. Jiang from CITIC Securities to raise a question, please. Coming next, let's welcome Jiang Wujing from CITIC Securities to raise a question. Thank you.
Thanks for the management team. My name is Jiang Wujing, coming from the CITIC Securities.
It is my great honor to witness the company's growth and the market value improvement. I have two questions. My first question, your GP margin and net profit are also in nice improvement. What are the key drivers for its sustainable improvement in the near future? The second one, for AI empowerment, what would be the key investment going to be for AI? And how likely the expense ratio would be further optimized? And what are we going to do with it? Thank you.
Thanks for Mr. Jiang. Because the question is related to the operations, financials, and the expense control, let's welcome our CFO, Ms. Fang, to help to respond to your question.
Thank you. Thanks for Mr. Jiang. Thanks for your question. So according to the financial report we released in H1 of this year, our GP margin growths are attributable to three factors. The first one is AI enablement. AI can help the doctors to improve their service efficiency.
Family Doctor, the service cost has been reduced by 52%. Second factor, our business structure continues to be improved, and you can see our service capacity continues to be extended. Our high margin service revenue contribution grew by 4%, which is a good improvement. Third factor is revenue from our platform. Concentration and contribution continue to go up. We'll continue to work with the high-quality supply chain resources to improve the contribution from the platform revenue. This also helps to boost the GP margin further. We're reducing the cost because of the technology empowerment, digitalized operation, and management, along with the economies of scale. You can see total expenses ratio and also the three fees rate all being optimized. For sure, the company will continue to leverage artificial intelligence to provide enterprises' health management service and also Senior Care Concierge service.
I surely believe such strategic investment and business presence will become the key for us to continue to improve our revenue and improve the performance as a whole. Well, when it comes to AI, the total investment in H1 of this year was RMB 160 million of flat growth, accounted for 22% of the total expenses. Our expense ratio is around 6.5%, a high level compared with other peers. But AI would be able to empower our doctor team and the management team by improving efficiency and the management quality. In H2 of this year, we're also going to continue to have AI investment. The total investment would be around RMB 40 million to continue to improve the AI capacities and be able to make sure AI be available for more applications. For example, critical ENEs, MDT consultations, which has already approved and used in breast cancer.
In the near future, we're also going to leverage AI to empower our middle and back office operations. In H1 of this year, our cost savings was more than 50%. In the near future, with digitalized operations and management, and I believe the economies of scale would continue to be demonstrated. Thank you.
Thanks, Ms. Fang. As has been mentioned, in H1 of this year, we continue to improve the profit and the revenue, leveraging AI enablement to make sure we harvest a robust financial business.
Let's now welcome our next analyst to raise a question.
Thank you. My name is David. I have a question regarding AI medical business. In H1 of this year, we see there is continued emergence of the AI medical product. Can the management team help us to work through the 7 Plus N Plus 1?
What would be the differentiation, and what would be your strengths? Ms. Fang also mentioned about AI expenses or the CapEx plan for H2 of this year. I have a question. You see, now we have more AI enablement scenarios continue to come up. What would be the future R&D strategies for AI enablement? Thank you.
Thanks for David for your question. It's a question related to AI technology application. Let's welcome Mr. He, our CTO, to help to respond to the question. Thank you. Thanks for David. Thanks for keeping an eye on our AI business development. AI is always a key competitiveness of Ping An Good Doctor. In H1 of 2025, we made two major breakthroughs. First of all, we do have a closed loop for data plus large language model plus scenarios.
Just like we mentioned, 7 Plus N Plus 1 full scenario enablement systems being officially released. Well, secondly, we also have AI plus the critical illness plus the general doctor, leveraging AI to do digital analytics and then to serve the patient with clinical decisions. You can see no matter for the service efficiency or quality, it's all been greatly improved. As the management team has already mentioned, actually, the accuracy rate is reaching 98%. Service cost per customer reduced by 52%. Our mid and back office operational efficiency improved by 50%. More importantly, and our AI service capacity per day can already reach 4 million consultations. And such capacity could also grow flexibly as our business continues to go up. There's no upper limit for that. We do enjoy some unique advantage.
First of all, we do have a large size of the data for the medical insurance along with large language model. Secondly, we also have a system continue to iterate and evolve our technology. Every year, we do have the consultations from 30,000 doctors and the data optimization. We're also going to engage more than 50 external experts to do the optimization to continue to improve our large language model performance. In the near future, there are two things we are committed. First of all, to strengthen our synergies for more application in the scenario and also make breakthroughs on critical questions to continue to improve our business model and operations.
Let's also leave the next question to Mr. Li from CICC, please. Coming next, let's welcome Li Jingyi from CICC to raise the next question, please.
Thank you. Thanks for the management team. My name is Li Jingyi from CICC. I have two questions to you. The first question, according to the business breakdown, you notice that the revenue from the B&D maintained a very good growth. So how are you going to comment on the positioning of the B&D business, especially enterprise management, health management studies? You may also see some competitors there. How likely the addressable market might be? What would be your competitive strength here? My second question is actually your traditional business that is a family doctor business. What is the existing operational strategies? In H1 of this year, I see family doctor, and we improved the customer number a lot. What is the driver behind such a nice growth? Thank you.
Thanks for Mr. Li for your questions. Those questions are related to the strategy and the business of the company. So let's welcome Mr. Li to respond to those questions.
Thank you to Madam Li for the question. Yes, indeed. The business growth of the company today had two clear channels, one coming from F-end and the other from the B-end. I think the corporate health management business has a strong driving force from the national policy, especially policies that are very friendly to the enterprise. With individuals' awareness for health continuing to improve, we believe that the B-end will be a very vital channel for our business growth. Since our business transformation from 2021, we know that the company today is a service provider for quality medical services. We will continue to optimize our family doctor's service hub, providing not only consultation but also intervention and services to our customers end-to-end close loop. Why do we want to reiterate such a strategy?
Because our persistence in medical care and healthcare coupled with AI capability will help the company to provide more diversified, individualized services, so when we fully design our capabilities from F&D, we will then scale it up at the B&D, so the Ping An Good Doctor has really refined our backbone. On basis of that, coupled with Ping An Group's extensive user resources, like more than 70,000 enterprise users with more than 20,000 large-scale or mid-scale enterprise users, with our core capability, with our advantage in data, we will be able to have great customer acquisition with improved service qualities so that we can deliver double win for our business, so simply said, the potential of the market is really unlimited. Today, we have already served more than 3,500 of them, and out of that 70,000 business enterprises, there's more to attain.
But without refining our backbone capability, it's difficult to further acquire customers. That's why we will continue to enhance our own capabilities and synergize with Ping An Group so that the customers for Ping An's insurance policies will all become our users eventually. Plus, on top of the family doctors, the B&D business is also growing robustly. It has also something to do with our core capabilities. For example, the 7 plus N plus 1 product mix and the large language models, especially like the doctor's workbench deployment, all of that will help the company to provide tiered services to individuals with precise services. Today, there are more than 35 million family doctor entitled members, and the daily per capita consultation is more than five times a day. We provide single scenario service online, and then with our four networks, we'll provide very compound service.
Simply said, the benefit users has been operated precisely and linking to their policies. For example, for senior and premium customers, we provide services that are fully embedded in their life policy. For example, in the first half of this year, we have a good product which covers the pre-hospitalization consultation, treatment, and after-treatment follow-ups for general users. We can also design differentiated products to expand the user traffic. As I said, today, we handle more than 4 million consultations, and with that capability, we'll expand the services to more Ping An's users. For family doctors, the key is to rely on AI to expand our users. Also, by the annotation, we can precisely operate these customers by innovating and linking these customers' different types and specifics with their policies. We will then improve the service quality and service efficiency for all these users.
Thank you to Mr. Li. Yes, our business focuses on senior care concierge and family doctors. Now, I'd like to move the question to our on-site attendees. Lady from second row.
Hello. I'm from Guangfa Securities. My name is Yang Linglin. I have two questions. Number one, a forward-looking question. I've been following the company for a long period of time, and I noted that your business has been improving, and your revenue during the reporting period grew by 20%, and your profit margin also 6.6%, and your profitability is continuously improving. So what's the outlook for the revenue growth in the next reporting period? Because on B&D today, your penetration is still very low. On F&D, the penetration still has room to grow. So can you give us an outlook on the revenue for both of these ends? And how about the GP margin profitability in the coming period?
My second question is, today, we know that China is aging. Everybody today taps into the potentials of the silver economy. So are you now working? You are now working around the silver economy with profound revenue growth and profitability growth. So my question is, what's your take on the senior care business? Today, people all talk about the senior care business, but the senior care industry itself had its own pain points. For example, today, many service providers are purely investing without generating great return. When do you think is the tipping point for us to have high ROI in the silver service industry, and what's your countermeasures? Thank you to Madam Yang for your question. Your first question is mostly on financial statistics and future outlook. I will ask Ms. Fang to take your question. Your second question is related to our homestay senior care service. So Mr.
Fang will take the question. Thank you to Madam Yang from GF Securities for following the company for such a long period of time.
Yes, in the first half of this year, we can see that after rounds of policy support, the healthcare service providers like the company have been developing really robustly. And today, with our differentiation and key strategy, our business growth has been driven by F&D and B&D growth. On one side, it is attributable to our synergy with Ping An Group. Our product power is improved. Our proactive service capability is improved, which provides the baseline for growth. On B&D, especially in relation to enterprise employee health services, we're now diversifying our offerings. With these two elements, the company's revenue is now improving with double digit GP margin. You can see that gross profit GP margin are all improving.
It's obviously a result of AI's assistance in reducing the cost. Our platform attributable revenue is also improving. On expenses, because of technology empowerment, technology enhancement, there are some scale-up economies there. The G&A and the general expenses, the sales expenses are all improving. Of course, the company will continue to invest on AI, B-end employee health, and homestay healthcare services, which will then help us to improve the revenue growth resilience. You can see the adjusted net profit amounting to 6.6%, which will grow further. I think it will reach double digit in interim. But how to stabilize such a great performance, especially against today's very complex environment? As management of the company, while we're deploying the company's growth with our strategies, we have four initiatives to stabilize our revenue and profitability growth. First is to optimize supply chain efficiency.
By value-added services, we want to build an open win-win ecosystem. Secondly, we will further consolidate end-to-end supply chain with users' traffic for centralized procurement to drive down the cost. Number three, we want to improve the platform-based revenue, especially by expanding its size and stabilizing the gross profit. The last initiative is to rely on AI empowerment so that we can further improve the leverage of the operation. I'm sure that the net profit of the company will continue to improve in the near future. That's all for me. On Silver Economy, I'd like to give you a quick response. Yes, the aging rate in China is deepening and accelerating. Over the last few years, Ping An Healthcare has been deeply involved in the industry with good performance and with some pains. I think we have a few clear understandings of the industry today.
First of all, the scale and the depth of the industry in China comes with very differentiated demands like homestay medical care. However, there are a few contradictions. First, the supply and demand is very imbalanced. Second, the cost is not compliant with the investment. In the industry, we have a number of intermediaries, agents, and insurance companies, but the payment capability of the users and how to manage the cost is not balanced today. The third problem is standard fulfillment does not comply with traditional value. The striking advantage here is to monetize your offer. Without capitalization and monetization, it's difficult to provide standardized service. While we have tried offering some personalized products, we know it's going to be a long way to provide standardized products.
Based on our acute understanding of the industry, especially on stay-at-home or homestay healthcare services, it's going to be our key because 90% of the elderly citizens are going to be staying at home, and only 73% of the senior citizens are going to stay in some institutions like elderly homes. As Chinese people's life expectancy continues to extend, we have to diversify the offering, so today the company has identified an asset-light service model. We have built three-in-one Senior Care Concierge, providing multi-scenarios of services by consolidating service providers. Such a model must be continued. We're going to make a few adaptations. For example, we're going to focus more on safety, rehabilitation, and care for homestay patients and elderly citizens. In the same time, we also need to link the resources from Ping An Good Doctor and Ping An Group.
In the last 10 years, we have built the family doctors as hub, and such a hub will empower the construction of family and homestay concierge, so on the other side, we need to continue to have AI empowerment. The payment issue, the imbalance between the cost and the investment is going to be something we have to address. Today, we're mostly empowering the insurance with our homestay services, but it will be further enhanced in the future. The third point I want to reiterate here is to synergize resources for senior care, either for safety or care. We need extensive supplier resources for safety. With smart equipment and sensors, we may be able to capture the risks for senior citizens staying at home, but today, we built such a systematic capability, not only identifying the risks but also mobilizing first-aid emergency teams to provide room or door-side support.
Such systematic capability will help us to provide more differentiated and premium services on care. We are now working with extensive service resources from our service stations by collaborating with PKU medical resources. We're also designing new products. Specifically speaking, on home care, we are going to further enhance our advantage, optimize our services, and try to generate great return.
Thank you very much, and thanks for Mr. Li for your wonderful presentation. As a flagship of the Ping An ecosystem, we'll continue to have our strategic commitment and excellent operations. I surely believe with concerted efforts of the management team, we will be able to create value to our investors and the society as a whole. Due to the time reason, the on-site and online Q&A session ends here. I really would like to thank for all your questions, and thanks for the management team for the response.
Due to the time reason, you may still have more questions, or you want to talk to us regarding more of our operations. We welcome you to browse our official website, and please contact our IR team if there's any need. Ladies and gentlemen, I'd like to announce the end of the 2025 interim results announcement. Let's welcome the management to leave the meeting room first. Thank you.